Außerordentliche Kündigung noch bestehender Abnahmeverpflichtungen des COVID-19-Impfstoffs Comirnaty

This proposal concerns the extraordinary termination of existing purchase obligations for the Comirnaty COVID-19 vaccine. It aims to address the current supply situation and avoid unnecessary expenditures for vaccine doses that are no longer required. This primarily affects the national health administration and the vaccine manufacturer. If approved, it would reduce the government's financial commitments regarding vaccine procurement.